TET1 and breast cancer: TET1 expression is decreased in lymph node metastasis BC tissue samples and metastatic BC cells (YCC-B1, MDA-MB-231, and BT549) compared with normal breast tissue samples and non-metastatic BC cells (BT474 and SK-BR3), and its expression inversely correlates with methylation level in its promoter [34,35].